Condensed Consolidated Statements of Cash Flows - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2025	Mar. 31, 2024
Cash flows from operating activities:
Net income (loss)	$ (3,236)	$ (5,607)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation and amortization	6,589	7,852
Equity-based compensation expense	6,346	5,923
Bad debt expense	1,592	1,314
Deferred income tax expense (benefit)	223	(202)
Fair value adjustments to contingent consideration	116	34
Settlement and impairment charges	619
Non-cash lease benefit	(768)	(705)
Non-cash debt charges	212	215
Other, net	243	(5)
Changes in operating assets and liabilities	(6,275)	562
Net cash provided by operating activities	5,661	9,381
Cash flows from investing activities:
Purchases of property, equipment and capitalization of software	(1,691)	(2,619)
Other		189
Net cash used in investing activities	(1,691)	(2,430)
Cash flows from financing activities:
Payments on debt	(1,150)	(1,150)
Dividends and dividend equivalents paid to Class A common stockholders	(324)	(585)
Payments related to tax withholding for share-based compensation	(4,237)	(2,498)
Payment of contingent consideration	(791)	(120)
Other financing	(29)
Net cash used in financing activities	(6,531)	(4,353)
Effect of exchange rate changes on cash	180	(925)
Net (decrease) increase in cash, cash equivalents and restricted cash	(2,381)	1,673
Cash, cash equivalents and restricted cash, beginning of period	169,287	125,763
Cash, cash equivalents and restricted cash, end of period	$ 166,906	$ 127,436